Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 18, 2025
Reporting period
Not applicable
Filed with the SEC
Jan 9, 2026
DirectorOther
Context
Classification
other
Code J — not an open-market trade
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001253886-26-000002
Filed / recorded
Jan 9, 2026, 3:56 AM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Jazz Pharmaceuticals plc
Issuer CIK
1232524
Ticker
JAZZ
Reporting person
Patrick G Enright
Relationship
Director
Security
Ordinary Shares
Table
Non-derivative (Table I)
Transaction date
Aug 18, 2025
Transaction code
J
Shares / units
5,000
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
21,379
Ownership form
Direct
Amendment
No
Footnotes from the filing
Shares transferred to former spouse without consideration as part of a comprehensive division of marital assets. Following the transfer, the reporting person no longer has beneficial ownership of the transferred shares.